Abstract:Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Background: Immunohistochemical (IHC) staining using archival tumor tissues is commonly used to study biomarkers of hepatocellular carcinoma (HCC). However, there are no biomarkers proven to be useful for personalized therapy of HCC so far. Since HCC is particularly susceptible to ischemia during and after the operation, the study sought to clarify the consistency of the IHC expression between biopsied and surgically resected HCC tissues. Methods: HCC patients who had both biopsy and hepatectomy tumor tissues were enrolled. IHC staining was done with rabbit antibodies (Cell Signaling, Beverly, MA, US.) against p-Akt (Ser473) and p-ERK1/2 (Thr202/Tyr204). The staining and its evaluation were performed by a pathologist who was blinded to the identification of the slides. The expression levels of both proteins were graded according to the percentage of positively stained cells in every section, as follows: negative: 0%; 1+: 1-10%; 2+: 10-50%, and 3+: > 50%. Staining results of biopsy and hepatectomy tissues were compared. Results: Forty-six tissue pairs were enrolled. The results of IHC staining were shown in the table. The expression was significantly decreased in hepatectomy tissues compared to biopsied tissue for both p-Akt and p-ERK (p < 0.001 and p < 0.001, respectively, by paired t test). The correlation of IHC staining results of paired tissues is poor. Spearman correlation coefficients for p-Akt (r = 0.116) and p-ERK (r = 0.112) were low. If using staining results as a continuous variable in analysis, the correlation between paired tissues remained poor, with Pearson correlation coefficients of 0.418 for p-Akt and 0.219 for p-ERK, respectively. Conclusions: The consistency of p-Akt and p-ERK IHC staining between preoperative biopsy and hepatectomy HCC tissues is poor. This confounding factor should be taken into account in data for biomarkers of HCC. (The study was supported by the grant of NSC 98-3112-B-002-038.) View this table: IHC staining results of p-Akt and p-ERK Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3759.

Relationship Between Apoptosis and Invasive and Metastatic Potential of Hepatocellular Carcinoma

Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues Are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma

Cell Proliferation, Apoptosis and the Related Regulators P27, P53 Expression in Hepatocellular Carcinoma

Expression and Clinical Significance of TAp73α, P53, PCNA and Apoptosis in Hepatocellular Carcinoma

The expression of apoptosis related proteins in hepatocellular carcinoma cell lines with different metastatic potentials

Clinical Implication of Keap1 and Phosphorylated Nrf2 Expression in Hepatocellular Carcinoma.

The Unique Characteristic in Peripheral Immune Cells in Patients with Advanced Hepatocellular Carcinoma.

Abstract 3759: Discordance of the immunohistochemical expression of phospho-Akt and phosphor-ERK between paired biopsy and hepatectomy specimens of hepatocellular carcinoma

Expression of P57kip2and Its Relationship with Clinicopathology, PCNA and P53 in Primary Hepatocellular Carcinoma

Expression of Survivin, P53 and Its Relationship with Apoptosis, Proliferation in Hepatocellular Carcinoma (HCC)

Expression of X-Linked Inhibitor-Of-Apoptosis Protein in Hepatocellular Carcinoma Promotes Metastasis and Tumor Recurrence

Relationships between survivin expression and cancer cell apoptosis, proliferation and p53 expression in hepatocellular carcinoma

Measures of Cell Turnover (apoptosis and Proliferation) and Their Association with Survival in Gastric Cancer

Regulation of HSP27 on NF-κB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis

Inhibition Of Apoptosis In Human Breast Cancer As Related To Prognosis

An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC)

Alterations of Oncogenes, Tumor Suppressor Genes and Growth Factors in Hepatocellular Carcinoma: with Relation to Tumor Size and Invasiveness.

The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody

Expression of PTEN in hepatocellular carcinoma and its relationship with p53, cell proliferation and apoptosis

Relationship Between PD-L1 Expression and CD8+ T-cell Immune Responses in Hepatocellular Carcinoma

Effect of the Expression of P27 on Cell Proliferation and Apoptosis in Hepatocellular Carcinoma